162 related articles for article (PubMed ID: 8609853)
1. Managing HIV. Part 5: Treating secondary outcomes. 5.4 HIV-induced neurological disease.
Wright EJ; Brew BJ; Currie JN; McArthur JC
Med J Aust; 1996 Apr; 164(7):414-7. PubMed ID: 8609853
[No Abstract] [Full Text] [Related]
2. Managing HIV. Part 3: Mechanisms of diseases. 3.7 How HIV leads to neurological disease.
Brew BJ; Wesselingh SL; Gonzales M; Heyes MP; Price RW
Med J Aust; 1996 Feb; 164(4):233-4. PubMed ID: 8604196
[No Abstract] [Full Text] [Related]
3. HIV-related neurological disease.
Brew BJ; Currie JN
Med J Aust; 1993 Jan; 158(2):104-8. PubMed ID: 8380482
[TBL] [Abstract][Full Text] [Related]
4. [Primary and secondary neurologic manifestations in AIDS].
Enzensberger W
Verh Dtsch Ges Inn Med; 1990; 96():524-9. PubMed ID: 2092477
[No Abstract] [Full Text] [Related]
5. [Neurologic problems in HIV infection. A current overview].
Enzensberger W; Fischer PA
Nervenarzt; 1990 Jun; 61(6):340-50. PubMed ID: 2198476
[No Abstract] [Full Text] [Related]
6. Managing HIV. Part 5: Treating secondary outcomes. 5.11 HIV and eye disease.
McCluskey PJ; Hall AJ; Lightman S
Med J Aust; 1996 Apr; 164(8):484-6. PubMed ID: 8614342
[TBL] [Abstract][Full Text] [Related]
7. Neurological manifestations of AIDS.
Seshadri S; Jain S; Maheshwari MC
J Assoc Physicians India; 1994 Apr; 42(4):309-10, 315. PubMed ID: 7860551
[No Abstract] [Full Text] [Related]
8. Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV.
Crowe S; Cooper DA; Chambers DE
Med J Aust; 1996 Mar; 164(5):290-5. PubMed ID: 8628165
[TBL] [Abstract][Full Text] [Related]
9. Pediatric neuro-AIDS. Update.
Belman AL
Neuroimaging Clin N Am; 1997 Aug; 7(3):593-613. PubMed ID: 9376970
[TBL] [Abstract][Full Text] [Related]
10. [Neurological complications of HIV infection. Review: new diagnostic, therapeutic and prognostic aspects].
Radziwill AJ; Kappos L; Battegay M; Steck AJ
Schweiz Med Wochenschr; 2000 Apr; 130(13):457-70. PubMed ID: 10812641
[TBL] [Abstract][Full Text] [Related]
11. Managing HIV. Part 5: Treating secondary outcomes. 5.1 HIV and skin disease.
Wong D; Shumack S
Med J Aust; 1996 Mar; 164(6):352-6. PubMed ID: 8606661
[TBL] [Abstract][Full Text] [Related]
12. Herpes virus infections, HIV, and disease progression. Recommended, not required.
Cotton D
AIDS Clin Care; 1995 Feb; 7(2):15. PubMed ID: 12212539
[No Abstract] [Full Text] [Related]
13. Dementia, neuropathy, and HIV. An interview with Justin C. McArthur, MB, BS, MPH. Interview by Mark Mascolini.
McArthur JC
J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):27-8, 31-4. PubMed ID: 11363695
[TBL] [Abstract][Full Text] [Related]
14. AIDS-related neurological disorders.
Guiloff RJ
Compr Ther; 1991 Jan; 17(1):57-68. PubMed ID: 1848174
[No Abstract] [Full Text] [Related]
15. Impact of current antiretroviral therapies on neuroAIDS.
Vivithanaporn P; Gill MJ; Power C
Expert Rev Anti Infect Ther; 2011 Apr; 9(4):371-4. PubMed ID: 21504390
[No Abstract] [Full Text] [Related]
16. Neurologic manifestations of HIV infection. Using imaging studies and antiviral therapy effectively.
Rachlis AR
Postgrad Med; 1998 Mar; 103(3):147-50, 153-61. PubMed ID: 9519035
[TBL] [Abstract][Full Text] [Related]
17. Parkinsonism with HIV infection.
Mirsattari SM; Power C; Nath A
Mov Disord; 1998 Jul; 13(4):684-9. PubMed ID: 9686775
[TBL] [Abstract][Full Text] [Related]
18. Fewer brain lesions with AZT.
Posit Aware; 1996; 7(1):7. PubMed ID: 11363133
[TBL] [Abstract][Full Text] [Related]
19. [New strategies in anti-HIV therapy--consequences for the neurologist?].
Enzensberger W; Fischer PA
Nervenarzt; 1996 Jun; 67(6):506-8. PubMed ID: 8767207
[No Abstract] [Full Text] [Related]
20. Managing HIV. Part 5: Treating secondary outcomes. 5.5 HIV and opportunistic neurological infections.
Jones PD; Beaman MH; Brew BJ
Med J Aust; 1996 Apr; 164(7):418-21. PubMed ID: 8609854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
